Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Novo Integrated Sciences, Inc. (NVOS)

    Price:

    0.00 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    NVOS
    Name
    Novo Integrated Sciences, Inc.
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    Price
    0.001
    Market Cap
    9.865k
    Enterprise value
    9.540M
    Currency
    USD
    Ceo
    Christopher Mehlin David
    Full Time Employees
    115
    Ipo Date
    2021-02-23
    City
    Bellevue
    Address
    11120 NE 2nd Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Life Healthcare Group Holdings Limited

    VALUE SCORE:

    6

    Symbol
    LTGHY
    Market Cap
    20.055B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    2nd position

    Bangkok Dusit Medical Services Public Company Limited

    VALUE SCORE:

    12

    Symbol
    BDUUF
    Market Cap
    305.152B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    The best

    Bangkok Dusit Medical Services Public Company Limited

    VALUE SCORE:

    12

    Symbol
    BDULF
    Market Cap
    320.669B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.001
    P/S
    0.002
    P/B
    0.001
    Debt/Equity
    0.316
    EV/FCF
    -1.633
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.613
    Earnings yield
    -1.765k
    Debt/assets
    0.147
    FUNDAMENTALS
    Net debt/ebidta
    -0.351
    Interest coverage
    -0.936
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.620
    Capex to operating cash flow
    -0.001
    Capex to revenue
    0.000
    Capex to depreciation
    0.002
    Return on tangible assets
    -1.350
    Debt to market cap
    477.430
    Piotroski Score
    1.000
    FUNDAMENTALS
    PEG
    0.000
    P/CF
    -0.004
    P/FCF
    -0.004
    RoA %
    -51.299
    RoIC %
    -19.595
    Gross Profit Margin %
    35.128
    Quick Ratio
    0.303
    Current Ratio
    0.371
    Net Profit Margin %
    -260.786
    Net-Net
    -0.739
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.127
    Revenue per share
    0.338
    Net income per share
    -0.882
    Operating cash flow per share
    -0.127
    Free cash flow per share
    -0.127
    Cash per share
    0.045
    Book value per share
    0.782
    Tangible book value per share
    -0.284
    Shareholders equity per share
    0.797
    Interest debt per share
    0.484
    TECHNICAL
    52 weeks high
    0.381
    52 weeks low
    0.000
    Current trading session High
    0.001
    Current trading session Low
    0.001
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    -15.542713%
    P/E
    -0.031
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    -80.60255%
    P/E
    -1.573
    logo

    Country
    SG
    Sector
    Consumer Defensive
    Industry
    Education & Training Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.514
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0.00681532%
    Payout Ratio
    11.472114999999999%
    P/E
    16.407
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.036
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.161
    DESCRIPTION

    Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

    NEWS
    https://images.financialmodelingprep.com/news/novo-integrated-sciences-reports-2024-fiscal-year-financial-results-20241218.jpg
    Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results

    businesswire.com

    2024-12-18 16:05:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-reports-fiscal-year-2024-third-quarter-20240719.jpg
    Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

    businesswire.com

    2024-07-19 17:00:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results.

    https://images.financialmodelingprep.com/news/whats-going-on-with-novo-integrated-sciences-stock-on-20240719.jpg
    What's Going On With Novo Integrated Sciences Stock On Friday?

    benzinga.com

    2024-07-19 11:54:49

    On Friday, Novo Integrated Sciences Inc NVOS announced it received notice of the commencement of disbursement for the complete monetization of a Standby Letter of Credit (SBLC).

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-receives-commencement-of-disbursement-notice-for-sblc-20240718.jpg
    Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

    businesswire.com

    2024-07-18 16:05:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-a-coil-spring-ready-to-explode-20240627.jpg
    Novo Integrated Sciences: A Coil Spring Ready To Explode

    seekingalpha.com

    2024-06-27 05:57:31

    Novo Integrated Sciences is a unique nano-cap company with the potential for massive growth through game-changing, non-dilutive financing. Novo is working towards closing 3 major funding transactions, including a $70M promissory note, $78M for the monetization of gemstones expected to deliver surplus cash, and a one-billion-dollar gold-backed bond. Success in securing funding will be a true inflection point for NVOS, dramatically changing the fortunes of the company for the better.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-receives-confirmation-of-issuance-of-sblc-20240613.jpg
    Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

    businesswire.com

    2024-06-13 16:30:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received confirmation of the issuance of a Standby Letter of Credit (“SBLC”) by HSBC for delivery by Swift MT760, as part of a program designed for monetizing SBLCs. As previously reported, the Company entered into an application for the monetizing program whereby the Company is projected to receive gross funding proceeds of approximately $78 million under the SB.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-board-of-directors-approves-increase-of-20240606.jpg
    Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

    businesswire.com

    2024-06-06 15:30:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company's Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The increased maximum amount available for purchase.

    https://images.financialmodelingprep.com/news/acenzia-selected-to-participate-in-protein-industries-canada-program-20240605.jpg
    Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products

    businesswire.com

    2024-06-05 15:00:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that its wholly owned Canadian subsidiary, Acenzia Inc. (“Acenzia”), has been selected by Protein Industries Canada to participate in a new project to bring new protein products with a superior nutritional amino acid profile to the global marketplace. The total project is expected to see approximately $5.4 million invested into the development, reformulation, and commerciali.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-and-rc-consulting-consortium-group-amend-20240603.jpg
    Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

    businesswire.com

    2024-06-03 15:00:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today the Company and RC Consulting Consortium Group LLC, in favor of SCP Tourbillion Monaco (“RC”), have amended the prepayment terms and conditions of the previously disclosed $70,000,000 promissory note, dated April 26, 2023 (the “RC Note”) to provide that, at any time after 12 months and no later than 60 months from the commencement of the term of the RC Note and prior to an e.

    https://images.financialmodelingprep.com/news/kbra-assigns-aa-to-pennsylvania-turnpike-commission-turnpike-revenue-20240603.jpg
    KBRA Assigns AA- to Pennsylvania Turnpike Commission Turnpike Revenue Bonds, Series C of 2024; Affirms Related Ratings

    businesswire.com

    2024-06-03 14:57:00

    NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a long-term rating of AA- to the Pennsylvania Turnpike Commission Turnpike Revenue Bonds, Series C of 2024. KBRA additionally affirms: The long-term rating of AA- for the Commission's outstanding Turnpike Revenue Bonds The long-term rating of A+ for the Commission's outstanding Turnpike Subordinate Revenue Bonds The long-term rating of AA- for the Commission's outstanding Motor License Fund-Enhanced Turnpike Subordinate Special Revenue Bonds The Outlook f.

    https://images.financialmodelingprep.com/news/why-is-novo-integrated-sciences-nvos-stock-up-139-20240531.jpg
    Why Is Novo Integrated Sciences (NVOS) Stock Up 139% Today?

    investorplace.com

    2024-05-31 12:15:58

    Novo Integrated Sciences (NASDAQ: NVOS ) stock is rocketing higher on Friday after the company said it wants to further maximize its stock repurchase program. Novo Integrated Sciences' Board of Directors is weighing options for a potential increase to the company's stock repurchase program.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-board-of-directors-conducting-strategic-review-20240531.jpg
    Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program

    businesswire.com

    2024-05-31 09:00:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-receives-confirmation-of-ready-willing-and-20240530.jpg
    Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

    businesswire.com

    2024-05-30 16:30:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-reports-fiscal-year-2024-second-quarter-20240415.jpg
    Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results

    businesswire.com

    2024-04-15 16:30:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-closes-on-6210000-securities-purchase-agreement-20240411.jpg
    Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement

    businesswire.com

    2024-04-11 17:00:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement.

    https://images.financialmodelingprep.com/news/novo-integrated-sciences-provides-update-on-certain-current-actions-20240326.jpg
    Novo Integrated Sciences Provides Update on Certain Current Actions and Events

    businesswire.com

    2024-03-26 14:30:00

    BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Certain Current Actions and Events.